Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Acute Low Back Pain Unresponsive to NSAIDs
NCT05851976Phase 4Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Oct 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in low back pain (LBP) comparing Naproxen + duloxetine with Naproxen + placebo (2 arms). Primary endpoint: Number of participants with moderate or severe Low Back Pain at 84 days. Started Oct 2023; status: recruiting.
02
Drugs
duloxetine
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT05851976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05851976.